Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

Drops for Eli Lilly and other influential companies are weighing on U.S. indexes Tuesday, even though most of the market is rising following an encouraging update on inflation.The S&P 500 was down 0.2 ...

The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...

Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...

Most U.S. stocks rose Jan. 14 following an encouraging update on inflation, but drops for pharmaceutical giant Eli Lilly and some other market heavyweights kept indexes in check. The S&P 500 edged up ...

We recently published a list of Jim Cramer Discussed These 18 Stocks As Inflation Dropped.In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against ...

A group of lawmakers are urging President Donald Trump to reject pharmaceutical companies’ efforts to pause the Biden ...